-
1021
Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility
Published 2021-05-01Subjects: “…polycystic ovary syndrome…”
Get full text
Article -
1022
-
1023
Exploring the molecular mechanisms by which per- and polyfluoroalkyl substances induce polycystic ovary syndrome through in silico toxicogenomic data mining
Published 2024-04-01“…The pathogeny of polycystic ovary syndrome (PCOS) is intricate, with endocrine disruptors (EDCs) being acknowledged as significant environmental factors. …”
Get full text
Article -
1024
Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome
Published 2019-08-01Subjects: “…Polycystic ovary syndrome…”
Get full text
Article -
1025
Validity of dual-energy X-ray absorptiometry scan in evaluation of trunk fat in non-obese patients with polycystic ovary syndrome
Published 2018-01-01“…To detect trunk obesity, which was claimed to be a major cause of insulin resistance, in nonobese patients with polycystic ovary syndrome (PCOS) by using dual-energy X-ray absorptiometry (DEXA) scan. …”
Get full text
Article -
1026
Insulin-like growth factor binding protein-1 and insulin in polycystic ovary syndrome: a systematic review and meta-analysis
Published 2023-12-01Subjects: Get full text
Article -
1027
Prevalence and knowledge of polycystic ovary syndrome (PCOS) and health-related practices among women of Syria: a cross-sectional study
Published 2024-12-01Subjects: “…Polycystic ovary syndrome…”
Get full text
Article -
1028
-
1029
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review
Published 2020-04-01Subjects: “…polycystic ovary syndrome…”
Get full text
Article -
1030
-
1031
Effect of C-reactive protein deficiency on insulin resistance reversal in rats with polycystic ovary syndrome through augmented leptin action
Published 2023-09-01Subjects: Get full text
Article -
1032
Identifying novel genetic loci associated with polycystic ovary syndrome based on its shared genetic architecture with type 2 diabetes
Published 2022-08-01Subjects: “…polycystic ovary syndrome…”
Get full text
Article -
1033
Ovary stereological features and serum biochemical factors following induction of polycystic ovary syndrome with testosterone enanthate in mice: An experimental study
Published 2018-04-01Subjects: “…Polycystic ovary syndrome…”
Get full text
Article -
1034
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives
Published 2022-08-01Subjects: Get full text
Article -
1035
Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.
Published 2018-12-01“…Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. …”
Get full text
Article -
1036
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study
Published 2021-04-01Subjects: “…Polycystic ovary syndrome…”
Get full text
Article -
1037
Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches
Published 2024-01-01“…Metformin is commonly prescribed to treat polycystic ovary syndrome (PCOS) patients, but in some cases, it may not be effective even at high doses or may cause intolerable side effects. …”
Get full text
Article -
1038
Determining the Risk of Premenopausal Endometrial Carcinoma by Analysing Expression of c-eErb-B2 in Patients with Polycystic Ovary Syndrome
Published 2010-04-01“…OBJECTIVE: The present study aims to determine the risk of premenopausal endometrial carcinoma by analyzing c-erb-B2 overexpression in patients with polycystic ovary syndrome (PCOS). STUDY DESIGN: A total of 20 women with PCOS, 20 premenopausal women under the age of 50 with endometrial carcinoma and 20 healthy women were eligible for the study. …”
Get full text
Article -
1039
-
1040
The impact of long non-coding RNA H19 on metabolic features and reproductive phenotypes of Egyptian women with polycystic ovary syndrome
Published 2024-01-01“…Abstract Background Polycystic ovary syndrome (PCOS) is known as the most common endocrine/metabolic disorder in women of reproductive age. …”
Get full text
Article